Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
6.47
-0.13 (-1.97%)
Mar 31, 2025, 10:57 AM EDT - Market open

Phathom Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Revenue
55.250.68---
Upgrade
Revenue Growth (YoY)
8001.47%----
Upgrade
Cost of Revenue
7.970.17---
Upgrade
Gross Profit
47.280.52---
Upgrade
Selling, General & Admin
290.66117.9310162.7427.52
Upgrade
Research & Development
34.0849.971.4472.3498.15
Upgrade
Operating Expenses
324.75167.83172.44135.08125.67
Upgrade
Operating Income
-277.47-167.31-172.44-135.08-125.67
Upgrade
Interest Expense
-72.01-41.97-27.31-6.79-4.58
Upgrade
Interest & Investment Income
15.167.882.130.041.09
Upgrade
Other Non Operating Income (Expenses)
-0.01-0.19-0.11-0.060.09
Upgrade
EBT Excluding Unusual Items
-334.33-201.59-197.72-141.88-129.07
Upgrade
Other Unusual Items
----2-
Upgrade
Pretax Income
-334.33-201.59-197.72-143.88-129.07
Upgrade
Net Income
-334.33-201.59-197.72-143.88-129.07
Upgrade
Net Income to Common
-334.33-201.59-197.72-143.88-129.07
Upgrade
Shares Outstanding (Basic)
6351393733
Upgrade
Shares Outstanding (Diluted)
6351393733
Upgrade
Shares Change (YoY)
23.18%31.11%5.72%11.36%192.32%
Upgrade
EPS (Basic)
-5.29-3.93-5.05-3.89-3.88
Upgrade
EPS (Diluted)
-5.29-3.93-5.05-3.89-3.88
Upgrade
Free Cash Flow
-266.91-139.21-147.57-148.79-70.73
Upgrade
Free Cash Flow Per Share
-4.22-2.71-3.77-4.02-2.13
Upgrade
Gross Margin
85.57%75.51%---
Upgrade
Operating Margin
-502.18%-24532.55%---
Upgrade
Profit Margin
-605.09%-29558.94%---
Upgrade
Free Cash Flow Margin
-483.07%-20412.61%---
Upgrade
EBITDA
-276.67-166.74-171.82-134.56-125.34
Upgrade
D&A For EBITDA
0.80.580.620.520.32
Upgrade
EBIT
-277.47-167.31-172.44-135.08-125.67
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q